1 January 2024 in ADMET and DMPK
Background and purpose: Many sectors use nanoparticles and dispose of them in the aquatic environment without deciding the fate of these particles. Experimental approach: To identify a benign species of nanoparticles which can cause minimum harm to the aquatic environment, a comparative study was done with chemically synthesized silver nanoparticles (AgNPs) and green tea mediated synthesis (GT/AgNP) in both in vitro using human alveolar cancer cell line (A549) and normal cell line (L132), and in in vivo with zebrafish embryos. Key results: The in vitro studies revealed that GT/AgNPs were less toxic to normal cells than cancer cells. The GT/AgNPs showed high biocompatibility for zebrafish embryos monitored microscopically for their developmental stages and by cumulative hatchability studies. The reduced hatchability found in the AgNPs-treated group was correlated by differential gene expression of zebrafish hatching enzymes (ZHE) (ZHE1 and ZHE2). Conclusion: The results indicated that nanoparticles can affect the hatching of zebrafish embryos and elicit toxicity at the gene level. .
28 March 2023 in Current Microbiology
1 July 2018 in Microbiological Research
25 September 2015 in Microbiologyopen
Analyses of mutations in genes coding for subunits of RNA polymerase always throw more light on the intricate events that regulate the expression of gene(s). Lon protease of Escherichia coli is implicated in the turnover of RcsA (positive regulator of genes involved in capsular polysaccharide synthesis) and SulA (cell division inhibitor induced upon DNA damage). Failure to degrade RcsA and SulA makes lon mutant cells to overproduce capsular polysaccharides and to become sensitive to DNA damaging agents. Earlier reports on suppressors for these characteristic lon phenotypes related the role of cochaperon DnaJ and tmRNA. Here, we report the isolation and characterization of two novel mutations in rpoB gene capable of modulating the expression of cps genes in Δlon strains of E. coli in concert with HNS. clpA, clpB, clpY, and clpQ mutations do not affect this capsule expression suppressor (Ces) phenotype. These mutant RNA polymerases affect rcsA transcription, but per se are not defective either at rcsA or at cps promoters. The results combined with bioinformatics analyses indicate that the weaker interaction between the enzyme and DNA::RNA hybrid during transcription might play a vital role in the lower level expression of rcsA. These results might have relevance to pathogenesis in related bacteria.
1 May 2023 in Archives of Materials Science and Engineering
The science that involves nano-sized particles have been shown to have a huge impact on a variety of research fields, such as electronics, medicine, engineering, robotics and technology. The involvement of biological agents in nanoscience helped in the origin of bionanotechnology, which is deeply rooted in therapeutic and medical applications. This review provides an initiative to understand the combination of biological molecules and nanoparticles in delivering a great impression in the world of therapeutics.Conjugation of nanoparticles with the biological molecules makes them more friendly for the living system by increasing biocompatibility and reducing toxicity.Growing research in this area has revealed the identification and characterization of numerous biological agents of nano-sized that can serve as better carrier systems. They are exploited in the development of advanced nanoparticle-based targeted drug delivery systems. In general, either the combined form or the one in the derived form of nanoparticles from different biological organisms provides a valuable understanding of their specifications and importance in different therapeutic aspects.The combined form of biological molecules and nanoparticles is not yet well understood, and this might provide a baseline for prospects.This review provides an understanding of biologically synthesized and conjugated nanoparticles and their potential as therapeutic norms and highlights their applications, especially in the clinical field.
20 August 2024 in Molecular Biotechnology